Celldex Therapeutics
CLDX
#4691
Rank
$1.96 B
Marketcap
$29.60
Share price
6.44%
Change (1 day)
11.36%
Change (1 year)

Celldex Therapeutics (CLDX) - Total assets

Total assets on the balance sheet as of September 2025 : $0.64 Billion USD

According to Celldex Therapeutics's latest financial reports the company's total assets are $0.64 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celldex Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$0.79 B70.17%
2023-12-31$0.46 B32%
2022-12-31$0.35 B-20.67%
2021-12-31$0.44 B88.54%
2020-12-31$0.23 B91.84%
2019-12-31$0.12 B-21.1%
2018-12-31$0.15 B-50.63%
2017-12-31$0.31 B-17.67%
2016-12-31$0.38 B13.56%
2015-12-31$0.33 B36.11%
2014-12-31$0.24 B-28.55%
2013-12-31$0.34 B176.48%
2012-12-31$0.12 B28.11%
2011-12-31$97.99 M-10.87%
2010-12-31$0.10 B-21.67%
2009-12-31$0.14 B101.11%
2008-12-31$69.79 M644.5%
2007-12-31$9.37 M-84.75%
2006-12-31$61.47 M68.66%
2005-12-31$36.45 M-20.42%
2004-12-31$45.8 M46.31%
2003-12-31$31.3 M-11.15%
2002-12-31$35.23 M-34.12%
2001-12-31$53.48 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Seagen
SGEN
$3.63 B 460.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
$0.23 B-63.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$1.46 B 125.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$90.14 B 13,801.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$208.73 B 32,089.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$82.46 B 12,616.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
$3.05 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA